Solid Support Quality Control for Fragile Diagnostic Species

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The quality of species used in analytical and diagnostic procedures, such as PET and targeted radiotherapy, is often compromised during transit from manufacturer to end user due to the fragile nature of these molecules and their short half-lives, making existing quality control methods inadequate.

Innovation Solution

A method for rapid quality control at the end user site using a solid support with a model system and time-resolved detection of species interactions, allowing for the verification of interaction presence and complex formation rates between species and models, ensuring reliable use in procedures.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If quality control is performed at the manufacturer site, then manufacturing precision is improved, but reliability deteriorates due to transit degradation of fragile species

Engineering Contradiction:
Improvequality control at manufacturer siteVSAvoidspecies integrity at end user site
Core Design Contradiction:
Manufacturing precisionVSReliability

Solution Approach 1:

The patent implements quality control measurements at the end user site immediately before the species is used in diagnostic or therapeutic procedures. This preliminary action ensures that any degradation occurring during transit is detected, and the species is verified to still meet quality criteria before administration to the patient, thereby resolving the contradiction between manufacturing precision and reliability.

Inventive Principle:
Principle #10Preliminary action

2Loss of time

If rapid quality control is implemented at end user site, then time loss is reduced, but measurement precision may deteriorate due to simplified testing

Engineering Contradiction:
Improvetransit and testing timeVSAvoidquality verification accuracy
Core Design Contradiction:
Loss of timeVSMeasurement precision

Solution Approach 1:

The patent extracts the essential quality control measurements from complex manufacturer-site testing and implements them at the end user site. By focusing on critical parameters such as species concentration, purity, and functional activity using streamlined but rigorous assays, the system achieves rapid verification without sacrificing measurement precision, thus resolving the time-loss versus precision contradiction.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent adapts quality control parameters to be suitable for rapid end user site testing while maintaining precision. This includes using stable reference standards, optimizing assay conditions for speed without compromising accuracy, and establishing acceptance criteria that ensure species quality despite the reduced time frame, thereby resolving the contradiction between rapid testing and measurement precision.

Inventive Principle:
Principle #35Parameter changes

3Measurement precision

If complex interaction detection is used, then measurement precision is improved, but device complexity increases

Engineering Contradiction:
Improveinteraction detection accuracyVSAvoidquality control system complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent employs intermediary elements such as capture antibodies, reference standards, and control reagents that facilitate precise interaction detection without requiring complex equipment. These intermediaries enable accurate measurement of species quality parameters through well-established biochemical interactions, resolving the contradiction between measurement precision and device complexity by achieving high accuracy through biochemical mediators rather than technological complexity.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method enables reliable quality control of species near the end user site, ensuring the integrity of analytical and diagnostic procedures by verifying the interaction and complex formation rates within a short time frame, even for fragile or short-lived species, thus enhancing patient safety and diagnostic accuracy.

Implementation Method 1

the species bind—specifically to objects of some kind

Methodology Applied
Scientific EffectBinding interaction:

Data Source

PatentUS8394646B2Method for the quality control of molecules or targets
Publication Date: 2013.03.12 RIGEVIEW DIAGNOSTICS
  • US8394646B2 patent drawing
  • US8394646B2 patent drawing
  • US8394646B2 patent drawing

AI summary

A method for quality control of species used in analytical or diagnostic or therapeutic procedures includes immobilization of a model of the malignancy to a solid support (121), contacting the solid support with species dissolved in liquid (122), measuring both the rate of formation of complex and absolute magnitude of number of complexes of model and species (123) and determining the quality of species by comparing the measured values with predetermined values.